Science Explorer Back to mapMap
Discussion
Company · London · United Kingdom

EVRAZ (United Kingdom)

In research, EVRAZ (United Kingdom) stands highest in Health Sciences (#11,783 of 16,688 worldwide), over all time.

World rank, 2022-now
#19,844
of 22,385 · #27,159 all time
Rank in United Kingdom
#723
of 862
Research works
250
▼ 9% vs 2018-21
Citations
1.5k
6.1 per fractional work
Top-10% rate
9.2%
all institutions 10.0%
vs its own fields
0.97×
1.00× is exactly expected
Open access
49%
world 40%
International
65%
world 18%

What is EVRAZ (United Kingdom) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #11,783 of 16,688 8.6%131

Each strip is that field's whole ranked pool, with the notch where EVRAZ (United Kingdom) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does EVRAZ (United Kingdom) work in?

In 2022-now, 53% of research at EVRAZ (United Kingdom) is in Health Sciences, 29% in Social Sciences. Its largest fields are Medicine (47%), Economics, Econometrics and Finance (18%), Psychology (6%). It does 2.1× the world's share of Health Sciences.

Health Sciences: 45 fractional works · 52.6% of its workMedicine: 40 fractional works · 47.3% of its workOncology: 5 fractional works · 5.5% of its workEpidemiology: 4 fractional works · 4.9% of its workPublic Health, Environmental and Occupational Health: 4 fractional works · 4.7% of its workPulmonary and Respiratory Medicine: 3 fractional works · 3.6% of its workHematology: 2 fractional works · 2.7% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 2.5% of its workGenetics: 2 fractional works · 2.4% of its workPediatrics, Perinatology and Child Health: 2 fractional works · 2.3% of its workRheumatology: 2 fractional works · 2.1% of its workPathology and Forensic Medicine: 2 fractional works · 1.9% of its workInfectious Diseases: 1 fractional works · 1.7% of its workSurgery: 1 fractional works · 1.6% of its workDermatology: 1 fractional works · 1.6% of its workPsychiatry and Mental health: 1 fractional works · 1.5% of its workPhysiology: 1 fractional works · 1.5% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 1.3% of its workNeurology: 1 fractional works · 1.2% of its workGastroenterology: 1 fractional works · 0.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 0.7% of its workUrology: 1 fractional works · 0.6% of its workHepatology: 0 fractional works · 0.4% of its workHealth Informatics: 0 fractional works · 0.4% of its workFamily Practice: 0 fractional works · 0.3% of its workEmergency Medicine: 0 fractional works · 0.3% of its workObstetrics and Gynecology: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.7% of its workHealth Professions: 4 fractional works · 5.3% of its workGeneral Health Professions: 3 fractional works · 3.8% of its workPharmacy: 0 fractional works · 0.6% of its workHealth Information Management: 0 fractional works · 0.4% of its workMedical Laboratory Technology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workSocial Sciences: 25 fractional works · 29.4% of its workEconomics, Econometrics and Finance: 15 fractional works · 17.7% of its workEconomics and Econometrics: 14 fractional works · 16.8% of its workFinance: 1 fractional works · 1.0% of its workPsychology: 6 fractional works · 6.5% of its workApplied Psychology: 2 fractional works · 2.6% of its workSocial Psychology: 1 fractional works · 1.6% of its workClinical Psychology: 1 fractional works · 1.3% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.6% of its workDevelopmental and Educational Psychology: 0 fractional works · 0.4% of its workSocial Sciences: 3 fractional works · 3.2% of its workHealth: 2 fractional works · 2.1% of its workSociology and Political Science: 0 fractional works · 0.4% of its workEducation: 0 fractional works · 0.4% of its workCommunication: 0 fractional works · 0.3% of its workDecision Sciences: 1 fractional works · 1.4% of its workStatistics, Probability and Uncertainty: 1 fractional works · 0.8% of its workGeneral Decision Sciences: 0 fractional works · 0.3% of its workManagement Science and Operations Research: 0 fractional works · 0.3% of its workBusiness, Management and Accounting: 1 fractional works · 0.6% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workLife Sciences: 10 fractional works · 11.3% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 4.8% of its workGenetics: 2 fractional works · 2.5% of its workMolecular Biology: 1 fractional works · 0.9% of its workCancer Research: 1 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.5% of its workImmunology and Microbiology: 4 fractional works · 4.2% of its workMicrobiology: 2 fractional works · 2.1% of its workImmunology: 2 fractional works · 2.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 1 fractional works · 1.3% of its workCellular and Molecular Neuroscience: 1 fractional works · 0.7% of its workNeurology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.7% of its workPharmacology: 1 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.0% of its workAgricultural and Biological Sciences: 0 fractional works · 0.3% of its workPhysical Sciences: 6 fractional works · 6.7% of its workMathematics: 3 fractional works · 3.9% of its workStatistics and Probability: 3 fractional works · 3.7% of its workModeling and Simulation: 0 fractional works · 0.3% of its workComputer Science: 1 fractional works · 1.5% of its workArtificial Intelligence: 1 fractional works · 1.0% of its workHuman-Computer Interaction: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEnvironmental Science: 1 fractional works · 0.9% of its workHealth, Toxicology and Mutagenesis: 1 fractional works · 0.9% of its workEngineering: 0 fractional works · 0.4% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workALL ITS WORKEVRAZ (UnitedKingdom)85fractional works, 2022-now
Life Sciences11%Physical Sciences7%Health Sciences53%Social Sciences29%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Medicine4047.3%
    2. Health Professions45.3%
    1. Economics, Econometrics and Finance1517.7%
    2. Psychology66.5%
    3. Social Sciences33.2%
    4. Decision Sciences11.4%
    5. Business, Management and Accounting10.6%
    1. Biochemistry, Genetics and Molecular Biology44.8%
    2. Immunology and Microbiology44.2%
    3. Neuroscience11.3%
    4. Pharmacology, Toxicology and Pharmaceutics10.7%
    5. Agricultural and Biological Sciences00.3%
    1. Mathematics33.9%
    2. Computer Science11.5%
    3. Environmental Science10.9%
    4. Engineering00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.06× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.89× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 4.19× its world share, 4 worksImmunology and Micro…Neuroscience: 0.81× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.91× its world share, 1 worksPharmacology, Toxico…Computer Science: 0.19× its world share, 1 worksComputer ScienceEngineering: 0.03× its world share, 0 worksEngineeringEnvironmental Science: 0.18× its world share, 1 worksEnvironmental ScienceMathematics: 3.32× its world share, 3 worksMathematicsHealth Professions: 2.00× its world share, 4 worksHealth ProfessionsMedicine: 2.46× its world share, 40 worksMedicineBusiness, Management and Accounting: 0.19× its world share, 0 worksBusiness, Management…Decision Sciences: 1.43× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 8.29× its world share, 15 worksEconomics, Econometr…Psychology: 2.12× its world share, 6 worksPsychologySocial Sciences: 0.25× its world share, 3 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 8.3×. Every wedge is a field page.

All 16 fields, with their numbers
  1. Economics, Econometrics and Finance8.29×15 works
  2. Immunology and Microbiology4.19×4 works
  3. Mathematics3.32×3 works
  4. Medicine2.46×40 works
  5. Psychology2.12×6 works
  6. Health Professions2.00×4 works
  7. Pharmacology, Toxicology and Pharmaceutics1.91×1 works
  8. Decision Sciences1.43×1 works
  9. Biochemistry, Genetics and Molecular Biology0.89×4 works
  10. Neuroscience0.81×1 works
  11. Social Sciences0.25×3 works
  12. Computer Science0.19×1 works
  13. Business, Management and Accounting0.19×0 works
  14. Environmental Science0.18×1 works
  15. Agricultural and Biological Sciences0.06×0 works
  16. Engineering0.03×0 works

Who are the top researchers at EVRAZ (United Kingdom)?

Ranked on the quality score, Tommi Tervonen, Kevin Marsh and Sharon MacLachlan lead among researchers whose main affiliation is EVRAZ (United Kingdom).

  1. 1 Tommi Tervonen United Kingdom · #449,795 worldwide 4.1k citations · 141 works
  2. 2 Kevin Marsh United Kingdom · #1,307,653 worldwide 3.7k citations · 142 works
  3. 3 Sharon MacLachlan United Kingdom · #1,709,460 worldwide 643 citations · 38 works
  4. 4 Andrew Paul Cox United Kingdom · #1,852,987 worldwide 879 citations · 58 works
  5. 5 Maria Koufopoulou United Kingdom · #1,884,213 worldwide 274 citations · 23 works
  6. 6 Erica Zaiser United Kingdom · #1,926,115 worldwide 399 citations · 23 works
  7. 7 Sumitra Sri Bhashyam United Kingdom · #2,045,616 worldwide 178 citations · 19 works
  8. 8 Ike Iheanacho United Kingdom · #2,046,784 worldwide 1.2k citations · 80 works
  9. 9 Ashley Duenas United Kingdom · #2,094,372 worldwide 221 citations · 17 works
  10. 10 Venediktos Kapetanakis United Kingdom · #2,619,175 worldwide 1k citations · 32 works
All ranked researchers at EVRAZ (United Kingdom)

What are the most cited papers from EVRAZ (United Kingdom)?

The most cited paper from EVRAZ (United Kingdom) is "Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force" (Praveen Thokala, Nancy J. Devlin, Kevin Marsh et al., 2016), with 755 citations. Next come "Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force" (486) and "Defining Patient Engagement in Research: Results of a Systematic Review and Analysis: Report of the ISPOR Patient-Centered Special Interest Group" (179).

Most cited papers
#PaperReleasedCitations
1 Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force Praveen Thokala, Nancy J. Devlin, Kevin Marsh et al. · Value in Health Open access 2016 755
2 Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force Kevin Marsh, Maarten J. IJzerman, Praveen Thokala et al. · Value in Health Open access Mar 2016 486
3 Defining Patient Engagement in Research: Results of a Systematic Review and Analysis: Report of the ISPOR Patient-Centered Special Interest Group Rachel L. Harrington, Maya Hanna, Elisabeth M. Oehrlein et al. · Value in Health ReviewOpen access 23 May 2020 179
4 Prodromal symptoms of multiple sclerosis in primary care Giulio Disanto, Chiara Zecca, Sharon MacLachlan et al. · Annals of Neurology 9 May 2018 176
5 Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward Rob M.P.M. Baltussen et al. · Value in Health Open access 16 Oct 2019 170
All 60 most cited papers, with filters and sorting

Which keywords describe research at EVRAZ (United Kingdom)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Epidemiology, Clinical Trials, Pathogenesis, Immunotherapy and Prognostic Factors.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology11▲ 3.2×45 topics
  2. Quality of Life10▲ 8.0×13 topics
  3. Cost-effectiveness Analysis8▲ 125×1 topic
  4. Health Utility Measures8▲ 125×1 topic
  5. Clinical Trials4▲ 6.5×8 topics
  6. Immunotherapy3▲ 5.3×8 topics
  7. Pathogenesis3▲ 7.3×8 topics
  8. Biomarkers3▲ 5.0×5 topics
  9. Prognostic Factors3▲ 7.5×6 topics
  10. Vaccine3▲ 7.9×4 topics
  11. Pharmaceutical Industry3▲ 84×2 topics
  12. Guidelines2▲ 6.3×5 topics
  13. Lymphoma2▲ 18×2 topics
  14. Bayesian Methods2▲ 54×2 topics
  15. Immunity2▲ 6.4×3 topics
  16. Chronic Disease Management2▲ 12×4 topics
  17. Drug Development Costs2▲ 97×1 topic
  18. Generic Drugs2▲ 97×1 topic
  19. Meta-Analysis2▲ 4.2×8 topics
  20. Leadership2▲ 4.9×6 topics
  21. Medication Adherence2▲ 42×2 topics
  22. Professional Development2▲ 12×4 topics
  23. Clinical Management2▲ 13×4 topics
  24. Genetic Variants2▲ 12×3 topics
  25. Rituximab2▲ 15×3 topics
  26. Drug Development2▲ 25×2 topics
  27. Experimental Design2▲ 60×2 topics
  28. Health Outcomes2▲ 7.8×3 topics
  29. Adverse Drug Reactions2▲ 38×2 topics
  30. COVID-19 Vaccine2▲ 28×1 topic
  31. Conjoint Analysis2▲ 53×1 topic
  32. Discrete Choice Models2▲ 72×1 topic
  33. Off-Label Drug Use2▲ 77×1 topic
  34. Pediatric Pharmacokinetics2▲ 77×1 topic
  35. Targeted Therapy2▲ 9.0×3 topics
  36. Vaccine Hesitancy2▲ 31×1 topic
  37. Bacterial Meningitis2▲ 87×1 topic
  38. Evidence-Based Practice2▲ 14×3 topics
  39. Neisseria meningitidis2▲ 87×1 topic
  40. Chronic Disease2▲ 11×2 topics

Which research topics does EVRAZ (United Kingdom) publish most on?

By volume in 2022-now: Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Economic and Environmental Valuation and Vaccine Coverage and Hesitancy.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 8 works
  2. 2 Pharmaceutical Economics and Policy Economics and Econometrics 2 works
  3. 3 Economic and Environmental Valuation Economics and Econometrics 2 works
  4. 4 Vaccine Coverage and Hesitancy Health 2 works
  5. 5 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 2 works
  6. 6 Bacterial Infections and Vaccines Microbiology 2 works
  7. 7 Economic and Financial Impacts of Cancer Economics and Econometrics 2 works
  8. 8 CAR-T cell therapy research Oncology 2 works
  9. 9 Global Health Care Issues General Health Professions 2 works
  10. 10 Statistical Methods in Clinical Trials Statistics and Probability 2 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.0%not open51.0%

World: 40% of research is openly available.

with international co-authors65.2%domestic only34.8%

World: 18% is written across borders.

How has EVRAZ (United Kingdom)'s research output changed?

Output in 2022-2025 was 9% lower than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is EVRAZ (United Kingdom) as a percentage of every work published that year, 0.00043% in 2024.

still counting0.00025%0.00050%0.00075%EVRAZ (United Kingdom)0.00022% in 20252020

Fractional works of EVRAZ (United Kingdom) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

5%10%15%EVRAZ (United Kingdom)10.9% in 2024all institutions10.0% in 20242020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 11.0% in 2023.

Other research institutions in London

All research institutions in London

Share EVRAZ (United Kingdom)'s ranking

EVRAZ (United Kingdom) on Science Explorer

A card with EVRAZ (United Kingdom)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about EVRAZ (United Kingdom). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.